MACOMPTA.fr (MLCMA) H1 2026 earnings summary

Executive summary

• Revenue for H1 2025/2026 increased by 29% year-over-year, reaching €2,155K, reflecting strong commercial momentum.

• EBITDA margin stood at 19%, with a net margin of 10% for the semester.

• Significant R&D investments, doubling year-over-year and representing 20.4% of revenue, focused on AI agents and electronic invoicing.

• The company maintains a strong financial structure with no financial debt and €388K in available cash after a €325K dividend payment.

• Confirmed ambition to transfer listing to Euronext Growth in H1 2026.

Financial highlights

• Revenue: €2,155K, up 29% from €1,671K in H1 2024/2025.

• EBITDA: €405K (19% margin), up from €384K; net income: €213K (10% margin), up from €206K.

• Operating income: €242K, slightly down from €254K due to increased investment.

• Shareholders' equity stood at €2,574K as of December 31, 2025.

• R&D investments doubled, with capitalized production rising to €441K from €167K.

Outlook and guidance

• Annual growth target maintained at 25–30% with an EBITDA margin goal of 25–30%.

• Launch of first AI agents planned for H1 2026; electronic invoicing platform to launch in Q3 2026.

• Ongoing rollout of new user interface and premium support offering in early 2026.